Biotech Takes Smaller Share Of Securities Suits In '08
Although the number of life science and pharmaceutical firms hit with class action securities lawsuits held fairly steady in 2008, they made up a far smaller percentage of the total number...To view the full article, register now.
Already a subscriber? Click here to view full article